Radnor Capital Management LLC Purchases New Position in The Clorox Company (NYSE:CLX)

Radnor Capital Management LLC purchased a new position in The Clorox Company (NYSE:CLXFree Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,392 shares of the company’s stock, valued at approximately $553,000.

A number of other institutional investors have also added to or reduced their stakes in the company. Innealta Capital LLC bought a new position in shares of Clorox in the second quarter worth approximately $30,000. Trifecta Capital Advisors LLC increased its position in shares of Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after purchasing an additional 130 shares during the last quarter. First Foundation Advisors bought a new stake in Clorox during the first quarter valued at approximately $31,000. Family Firm Inc. bought a new position in Clorox in the second quarter worth approximately $31,000. Finally, Quarry LP increased its stake in shares of Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after purchasing an additional 114 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Wall Street Analysts Forecast Growth

CLX has been the subject of several analyst reports. Barclays increased their target price on shares of Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a report on Friday, November 1st. Wells Fargo & Company decreased their price target on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a research note on Wednesday, July 10th. BNP Paribas raised shares of Clorox to a “strong sell” rating in a report on Friday, September 6th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and lifted their price objective for the stock from $155.00 to $170.00 in a research note on Wednesday. Finally, Citigroup upped their price target on shares of Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, September 6th. Five investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, Clorox currently has a consensus rating of “Hold” and a consensus price target of $155.00.

View Our Latest Stock Analysis on Clorox

Insider Buying and Selling

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.57% of the stock is currently owned by company insiders.

Clorox Trading Up 0.2 %

Clorox stock opened at $162.70 on Thursday. The stock’s 50 day simple moving average is $161.89 and its two-hundred day simple moving average is $146.58. The firm has a market cap of $20.14 billion, a PE ratio of 56.69, a P/E/G ratio of 3.11 and a beta of 0.41. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $169.09. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLXGet Free Report) last announced its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter last year, the firm posted $0.49 EPS. The business’s revenue was up 27.0% on a year-over-year basis. Analysts anticipate that The Clorox Company will post 6.81 earnings per share for the current year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be issued a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a yield of 3.00%. Clorox’s payout ratio is 170.03%.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.